66 related articles for article (PubMed ID: 27558125)
21. No Association of IFNL4 Genotype With Opportunistic Infections and Cancers Among Men With Human Immunodeficiency Virus 1 Infection.
Fang MZ; Jackson SS; Pfeiffer RM; Kim EY; Chen S; Hussain SK; Jacobson LP; Martinson J; Prokunina-Olsson L; Thio CL; Duggal P; Wolinsky S; O'Brien TR
Clin Infect Dis; 2023 Feb; 76(3):521-527. PubMed ID: 36573283
[TBL] [Abstract][Full Text] [Related]
22. IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients.
Franco S; Aparicio E; Parera M; Clotet B; Tural C; Martinez MA
AIDS; 2014 Jan; 28(1):133-6. PubMed ID: 24072198
[TBL] [Abstract][Full Text] [Related]
23. Human herpesvirus 8 infection is associated with prostate cancer among IFNL4-ΔG carriers.
Jenkins FJ; Minas TZ; Tang W; Dorsey TH; Ambs S
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):338-346. PubMed ID: 35468990
[TBL] [Abstract][Full Text] [Related]
24.
Meza G; Galián F; Jaimes-Bernal C; Márquez FJ; Sinangil F; Scagnolari C; Real LM; Forthal D; Caruz A
Virulence; 2022 Dec; 13(1):757-763. PubMed ID: 35481423
[TBL] [Abstract][Full Text] [Related]
25.
Tang W; Wallace TA; Yi M; Magi-Galluzzi C; Dorsey TH; Onabajo OO; Obajemu A; Jordan SV; Loffredo CA; Stephens RM; Silverman RH; Stark GR; Klein EA; Prokunina-Olsson L; Ambs S
Clin Cancer Res; 2018 Nov; 24(21):5471-5481. PubMed ID: 30012562
[No Abstract] [Full Text] [Related]
26. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy.
Imami N; Antonopoulos C; Hardy GA; Gazzard B; Gotch FM
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1499-508. PubMed ID: 10580400
[TBL] [Abstract][Full Text] [Related]
27. Interferon lambda4 polymorphism is not associated with human papillomavirus infection outcome.
Cannella F; Scagnolari C; Statzu M; Sciandra I; Recine N; d'Ettorre G; Antonelli G; Pierangeli A
Virus Genes; 2018 Apr; 54(2):319-322. PubMed ID: 29243064
[TBL] [Abstract][Full Text] [Related]
28. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels.
Jouvin-Marche E; Macek Jílková Z; Thelu MA; Marche H; Fugier E; Van Campenhout N; Hoang XS; Marlu A; Sturm N; Callanan M; Leroy V; Zarski JP; Marche PN
J Infect Dis; 2014 Jun; 209(12):1907-15. PubMed ID: 24415789
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study.
Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J;
J Viral Hepat; 2015 Sep; 22(9):708-17. PubMed ID: 25580520
[TBL] [Abstract][Full Text] [Related]
30. A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.
Dillon SM; Guo K; Austin GL; Gianella S; Engen PA; Mutlu EA; Losurdo J; Swanson G; Chakradeo P; Keshavarzian A; Landay AL; Santiago ML; Wilson CC
AIDS; 2018 Jul; 32(12):1599-1611. PubMed ID: 29762170
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphism in IFNL4 and response to pegylated interferon-α and ribavirin in Japanese chronic hepatitis C patients.
Nozawa Y; Umemura T; Katsuyama Y; Shibata S; Kimura T; Morita S; Joshita S; Komatsu M; Matsumoto A; Yoshizawa K; Ota M; Tanaka E
Tissue Antigens; 2014 Jan; 83(1):45-8. PubMed ID: 24355007
[TBL] [Abstract][Full Text] [Related]
32. Enterovirus Exposure Uniquely Discriminates Type 1 Diabetes Patients with a Homozygous from a Heterozygous Melanoma Differentiation-Associated Protein 5/Interferon Induced with Helicase C Domain 1 A946T Genotype.
Schulte BM; Gielen PR; Kers-Rebel ED; Prosser AC; Lind K; Flodström-Tullberg M; Tack CJ; Elving LD; Adema GJ
Viral Immunol; 2016 Sep; 29(7):389-97. PubMed ID: 27482829
[TBL] [Abstract][Full Text] [Related]
33. Distribution of
Sorrentino L; Silvestri V; Oliveto G; Scordio M; Frasca F; Fracella M; Bitossi C; D'Auria A; Santinelli L; Gabriele L; Pierangeli A; Mastroianni CM; d'Ettorre G; Antonelli G; Caruz A; Ottini L; Scagnolari C
Microorganisms; 2022 Feb; 10(2):. PubMed ID: 35208821
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.
Iqbal K; Imran M; Ullah S; Jamal M; Waheed Y
Curr HIV Res; 2018; 16(4):297-301. PubMed ID: 30338740
[TBL] [Abstract][Full Text] [Related]
35. MxA induction may predict sustained virologic responses of chronic hepatitis B patients with IFN-alpha treatment.
Kong XF; Zhang XX; Gong QM; Gao J; Zhang SY; Wang L; Xu J; Han Y; Jin GD; Jiang JH; Zhang DH; Lu ZM
J Interferon Cytokine Res; 2007 Sep; 27(9):809-18. PubMed ID: 17892402
[TBL] [Abstract][Full Text] [Related]
36. Expression of cytokine-mRNA in peripheral blood mononuclear cell of human immunodeficiency virus-1 subtype C infected individuals with opportunistic viral infections from India (South).
Sachithanandham J; Ramalingam VV; Raja J; Abraham OC; Pulimood SA; Kannangai R
Indian J Med Microbiol; 2016; 34(1):76-81. PubMed ID: 26776123
[TBL] [Abstract][Full Text] [Related]
37. Association of DC-SIGNR Expression in Peripheral Blood Mononuclear Cells with DC-SIGNR Genotypes in HIV-1 Infection.
Chaudhary O; Kumar S; Bala M; Singh J; Hazarika A; Luthra K
Viral Immunol; 2015 Oct; 28(8):472-5. PubMed ID: 26313015
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.
Hamdi N; El-Akel W; El-Serafy M; Esmat G; Sarrazin C; Abdelaziz AI
Intervirology; 2012; 55(3):210-8. PubMed ID: 21597279
[TBL] [Abstract][Full Text] [Related]
39. Expression levels of the innate response gene RIG-I and its regulators RNF125 and TRIM25 in HIV-1-infected adult and pediatric individuals.
Britto AM; Amoedo ND; Pezzuto P; Afonso AO; Martínez AM; Silveira J; Sion FS; Machado ES; Soares MA; Giannini AL
AIDS; 2013 Jul; 27(12):1879-85. PubMed ID: 24131985
[TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy, pharmacokinetic, pharmacodynamic activity, and interferon stimulated gene expression of different interferon formulations in HIV/HCV genotype-1 infected patients.
Osinusi A; Bon D; Nelson A; Lee YJ; Poonia S; Shivakumar B; Cai SY; Wood B; Haagmans B; Lempicki R; Herrmann E; Sneller M; Polis M; Masur H; Kottilil S
J Med Virol; 2014 Feb; 86(2):177-85. PubMed ID: 24166150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
